期刊文献+

增生性玻璃体视网膜病变治疗的研究进展 被引量:1

下载PDF
导出
摘要   1 PVR的发病机理   PVR的发生过程,一般经过炎症反应、细胞增殖和瘢痕形成3个阶段[1].其中,视网膜裂孔和血眼屏障的破坏可能是关键因素,具备这两个因素的患者发生PVR的机率大大高于不具备这两个因素的患者.   ……
出处 《重庆医科大学学报》 CAS CSCD 2006年第z1期55-57,共3页 Journal of Chongqing Medical University
  • 相关文献

参考文献21

  • 1[1]Pastor JC.Proliferative vitreoretinopathy:an overview[J].Surv Ophthalmol,1998;43:3-18.
  • 2宋宗明,惠延年.白细胞介素1与增生性玻璃体视网膜病变[J].国外医学(眼科学分册),2002,26(4):231-235. 被引量:4
  • 3[3]Jaffe GJ,Van Le L,Valea F,et al.Expression of interleukin-1 alpha,interleukin-1 beta,and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells[J].Exp Eye Res,1992;55 (2):325-335.
  • 4[4]Charteris DG.Proliferative vitreoretinopathy:Path o biology,surgical management and adjunctive treatment[J].Br J Ophthalmol,1995;79:953-960.
  • 5[5]Bochaton-Piallat ML,Kapetanios A,Donati G,et al.TGF-b1,TGFb receptor Ⅰ and DE-A fibronectin expression in myofibroblasts of vitreoretinopathy[J].Invest Ophthamol Vis Sci,2000;41:2336-2342.
  • 6[6]Kekul,Dennis.Proliferative diabetic retinopathy[J].International Ophthalmology Clinics,2004;44(4):69-84.
  • 7[7]Khaled,michael.Retinopathy of Prematurity:Practical Surgical Management in the New Millennium[J].Techniques in Opthalmology,2004;2(2):60-65.
  • 8陈松,王景昭,程景宁,徐日理,陈惠茹,翁乃清,张尔平,刘武,魏文斌.复杂性孔源性视网膜脱离的玻璃体视网膜手术失败原因初步探讨[J].中华眼科杂志,1998,34(6):424-427. 被引量:14
  • 9李松峰,刘恬,张少冲.药物在增生性玻璃体视网膜病变治疗中的应用[J].眼科新进展,2003,23(3):209-211. 被引量:4
  • 10[10]Rubsamen PE,Cousins SW.Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy[J].Retina,1997(17):44-50.

二级参考文献58

  • 1刘诗平 陈尚猛 等.槲皮素及衍生物的生物活性研究进展[J].中草药,1991,22:182-186.
  • 2张椿年.近年来国外阿霉素实验和临床研究进展[J].国外药学(生化制药),1983,4(1):1-1.
  • 3易大年 徐光漪.核磁共振波谱-在药物分析中的应用[M].上海:上海科学技术出版社,1985.293.
  • 4Campochiaro PA. Pathogenic mechanisms in proliferative vitreoretinopathy[J]. Arch Ophthalmol 1997; 115:237-241.
  • 5Girard P ,Mimoun G, Karpouzas I, Montefiore G. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery[J]. Retina 1994 ; 14:417-424.
  • 6Pastor JC. Proliferative vitreoretinopathy :an overview[J]. Surv Ophthalmol 1998, 43:3-18.
  • 7Weller M, Wiedemann P, Heimann K. Proliferative vitreoretinopathy[J]. Int Ophthalmol 1990,14:105-117.
  • 8Casaroli R, Vilaró S . The role of fibronectin , laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy[J]. Invest Ophthalmol Vis Sci 1994 ; 35:2791-2803.
  • 9David G. Proliferative vitreoretinopathy., pathobiology,surgical management, and adjunctive treatment [J]. Br J Ophthalmol 1995,79:935-960.
  • 10Casaroli R,Pagan R,Vilaró S. Epithelial-mesenehymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells[J]. Invest Ophthalmol Vis Sci 1999; 40: 2062-2072.

共引文献45

同被引文献6

  • 1王静波,惠延年,韩泉洪,张鹏.细胞因子对人视网膜色素上皮细胞syndecan-1表达的影响[J].中华眼底病杂志,2006,22(2):113-116. 被引量:8
  • 2Lopez P F, Grossniklaus H E, Lambert H M, et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration[J]. Am J Ophthalmol, 1991,112(6) :647-656.
  • 3Wakefield D, Lloyd A. The role of cytokines in the pathagenesis of inflammatory eye disease[J]. Cytokine, 1992,4( 1 ) : 1-5.
  • 4Limb G A, Little B C, Meager A, et al. Cytokines in proliferative vitreoretinopathy[J]. Eye, 1991,5 ( Pt 6) : 686-693.
  • 5Cheng T H,Shih N I,Chen C H,el al. Role of mitogen-activated protein kinase pathway in reactive oxygen species-medicated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy[J]. J Biomed Sci JT. 2005,12( 1 ) : 123-133.
  • 6王静波,张延军,惠延年.细胞因子对培养的人视网膜色素上皮细胞早期生长反应基因-1的影响[J].中华眼底病杂志,2007,23(6):410-413. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部